These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 28799854)
81. Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF). Maurer MH Mass Spectrom Rev; 2010; 29(1):17-28. PubMed ID: 19116946 [TBL] [Abstract][Full Text] [Related]
82. Chromogranin A levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Verde F; Steinacker P; Oeckl P; Weishaupt JH; Rosenbohm A; Silani V; Ludolph AC; Otto M Neurobiol Aging; 2018 Jul; 67():21-22. PubMed ID: 29609078 [TBL] [Abstract][Full Text] [Related]
83. Proteomic analysis of cerebrospinal fluid of amyotrophic lateral sclerosis patients in the presence of autologous bone marrow derived mesenchymal stem cells. Reis ALG; Maximino JR; Lage LAPC; Gomes HR; Pereira J; Brofman PRS; Senegaglia AC; Rebelatto CLK; Daga DR; Paiva WS; Chadi G Stem Cell Res Ther; 2024 Sep; 15(1):301. PubMed ID: 39278909 [TBL] [Abstract][Full Text] [Related]
84. Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Frutiger K; Lukas TJ; Gorrie G; Ajroud-Driss S; Siddique T Amyotroph Lateral Scler; 2008 Jun; 9(3):184-7. PubMed ID: 18574763 [TBL] [Abstract][Full Text] [Related]
85. Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis Diagnosis. Mitropoulos K; Katsila T; Patrinos GP; Pampalakis G OMICS; 2018 Jan; 22(1):52-64. PubMed ID: 29356625 [TBL] [Abstract][Full Text] [Related]
86. Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid. Bastos P; Ferreira R; Manadas B; Moreira PI; Vitorino R Crit Rev Clin Lab Sci; 2017 May; 54(3):185-204. PubMed ID: 28393582 [TBL] [Abstract][Full Text] [Related]
87. Proteomes of Paired Human Cerebrospinal Fluid and Plasma: Relation to Blood-Brain Barrier Permeability in Older Adults. Dayon L; Cominetti O; Wojcik J; Galindo AN; Oikonomidi A; Henry H; Migliavacca E; Kussmann M; Bowman GL; Popp J J Proteome Res; 2019 Mar; 18(3):1162-1174. PubMed ID: 30702894 [TBL] [Abstract][Full Text] [Related]
88. Alterations in muscle proteome of patients diagnosed with amyotrophic lateral sclerosis. Elf K; Shevchenko G; Nygren I; Larsson L; Bergquist J; Askmark H; Artemenko K J Proteomics; 2014 Aug; 108():55-64. PubMed ID: 24846852 [TBL] [Abstract][Full Text] [Related]
89. Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment. Wormser U; Mandrioli J; Vinceti M; Fini N; Sintov A; Brodsky B; Proskura E; Finkelstein Y J Neuroinflammation; 2016 Jun; 13(1):131. PubMed ID: 27245439 [TBL] [Abstract][Full Text] [Related]
91. UCHL1 from serum and CSF is a candidate biomarker for amyotrophic lateral sclerosis. Li R; Wang J; Xie W; Liu J; Wang C Ann Clin Transl Neurol; 2020 Aug; 7(8):1420-1428. PubMed ID: 32729234 [TBL] [Abstract][Full Text] [Related]
92. Manganese in cerebrospinal fluid and blood plasma of patients with amyotrophic lateral sclerosis. Roos PM; Lierhagen S; Flaten TP; Syversen T; Vesterberg O; Nordberg M Exp Biol Med (Maywood); 2012 Jul; 237(7):803-10. PubMed ID: 22859739 [TBL] [Abstract][Full Text] [Related]
93. Cerebrospinal fluid from amyotrophic lateral sclerosis patients causes fragmentation of the Golgi apparatus in the neonatal rat spinal cord. Ramamohan PY; Gourie-Devi M; Nalini A; Shobha K; Ramamohan Y; Joshi P; Raju TR Amyotroph Lateral Scler; 2007 Apr; 8(2):79-82. PubMed ID: 17453633 [TBL] [Abstract][Full Text] [Related]
94. Increased levels of MIP-1α in CSF and serum of ALS. Yang X; Gao L; Wu X; Zhang Y; Zang D Acta Neurol Scand; 2016 Aug; 134(2):94-100. PubMed ID: 26427609 [TBL] [Abstract][Full Text] [Related]
95. Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis. Weydt P; Oeckl P; Huss A; Müller K; Volk AE; Kuhle J; Knehr A; Andersen PM; Prudlo J; Steinacker P; Weishaupt JH; Ludolph AC; Otto M Ann Neurol; 2016 Jan; 79(1):152-8. PubMed ID: 26528863 [TBL] [Abstract][Full Text] [Related]
96. Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis. Wilson ME; Boumaza I; Lacomis D; Bowser R PLoS One; 2010 Dec; 5(12):e15133. PubMed ID: 21151566 [TBL] [Abstract][Full Text] [Related]
97. Association of cerebrospinal fluid levels of lateral olfactory tract usher substance (LOTUS) with disease activity in multiple sclerosis. Takahashi K; Kurihara Y; Suzuki Y; Goshima Y; Tanaka F; Takei K JAMA Neurol; 2015 Feb; 72(2):176-9. PubMed ID: 25437093 [TBL] [Abstract][Full Text] [Related]
98. Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis. Liu J; Gao L; Zang D PLoS One; 2015; 10(9):e0136937. PubMed ID: 26332465 [TBL] [Abstract][Full Text] [Related]
99. Some CSF Kynurenine Pathway Intermediates Associated with Disease Evolution in Amyotrophic Lateral Sclerosis. Alarcan H; Chaumond R; Emond P; Benz-De Bretagne I; Lefèvre A; Bakkouche SE; Veyrat-Durebex C; Vourc'h P; Andres C; Corcia P; Blasco H Biomolecules; 2021 May; 11(5):. PubMed ID: 34063031 [TBL] [Abstract][Full Text] [Related]